Lin, T <br/><br/>
Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis.  [electronic resource] 

 -  International journal of clinical practice  Apr 2012 
 - 399-408 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1742-1241 
<br/><br/><label>Standard No.: </label>10.1111/j.1742-1241.2011.02806.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alendronate--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Denosumab<br/>Drug-Related Side Effects and Adverse Reactions<br/>Female<br/>Humans<br/>Multicenter Studies as Topic<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Treatment Outcome